Literature DB >> 6381530

New principle for the simultaneous detection of total and immunoglobulin M antibodies applied to the measurement of antibody to hepatitis B core antigen.

G Angarano, L Monno, T A Santantonio, G Pastore.   

Abstract

A new test principle for the simultaneous detection of total approximate titers and immunoglobulin M antibodies has been developed and applied to the detection of antibody to hepatitis B core antigen. The method is based on the combination of a competition radioimmunoassay, for the determination of total antibody titer, with an indirect enzyme-linked immunosorbent assay for the determination of single class antibodies. The interference of the rheumatoid factor was avoided by including heat-aggregated immunoglobulin G in the dilution buffer. The specificity, sensitivity, and clinical application of the test are discussed. The results presented suggest that the simultaneous detection of total and immunoglobulin M antibody to hepatitis B core antigen might be helpful in the differentiation between previous and recent or ongoing hepatitis B infection, as well as in the differential diagnosis of acute hepatitis, in monitoring viral activity in chronic infections, and in helping to differentiate acute from chronic infections. The test principle appears applicable in the accurate diagnosis of other infectious diseases by a single test on only one serum sample.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381530      PMCID: PMC271210          DOI: 10.1128/jcm.19.6.905-910.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Hepatitis B core antibody in volunteer blood donors: comparison of radioimmunoassay and indirect immunofluorescence.

Authors:  J N Katchaki; T H Siem; R Brouwer
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

2.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

3.  [Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis].

Authors:  G Angarano; S Coppola; V Frappampina; L Monno; T Santantonio
Journal:  Boll Ist Sieroter Milan       Date:  1982

4.  Radioimmunoassay diagnosis of hepatitis type A.

Authors:  G Pastore; G Angarano; P Dentico; O Schiraldi
Journal:  Lancet       Date:  1979-04-21       Impact factor: 79.321

5.  Serological evidence of presence of HBsAg undetectable by conventional radioimmunoassay in anti-HBc positive blood donors.

Authors:  J N Katchaki; T H Siem; R Brouwer
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

Review 6.  Predictive value of markers of hepatitis virus infection.

Authors:  F Deinhardt
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

7.  Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen.

Authors:  W H Gerlich; W Lüer; R Thomssen
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

8.  The IgM antibody responses to the core antigen of hepatitis B virus.

Authors:  B J Cohen
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

9.  The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen.

Authors:  M Rizzetto; J W Shih; J L Gerin
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

10.  Selective detection of IgM-antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay.

Authors:  W H Gerlich; W Lüer
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

View more
  1 in total

1.  Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.

Authors:  W H Gerlich; A Uy; F Lambrecht; R Thomssen
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.